Risk factors of postoperative deep vein thrombosis (DVT) under low molecular weight heparin (LMWH) prophylaxis in patients with thoracolumbar fractures caused by high-energy injuries

被引:20
|
作者
Wang, Haiying [1 ]
Pei, Honglei [2 ]
Ding, Wenyuan [1 ]
Yang, Dalong [1 ]
Ma, Lei [1 ]
机构
[1] Hebei Med Univ, Hosp 3, Dept Spinal Surg, 139 Ziqiang St, Shijiazhuang 050051, Hebei, Peoples R China
[2] Hebei Med Univ, Hosp 1, Dept Orthopaed, Shijiazhuang 050000, Hebei, Peoples R China
关键词
Deep vein thrombosis; Low molecular weight heparin; Thoracolumbar fracture; High-energy injury; Risk factor; QUALITY-OF-LIFE; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; SPINAL SURGERY; SINGLE-CENTER; PREVALENCE; PREVENTION; DIAGNOSIS; DISEASE; TRAUMA;
D O I
10.1007/s11239-020-02192-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the incidence of DVT and to evaluate the risk factors of DVT under LMWH prophylaxis in patients with thoracolumbar fractures caused by high-energy injuries postoperatively. A total of 534 patients from January 2016 to November 2019 were included in this retrospective study. Medical record data, including demographic data, perioperative variables, and laboratory results, were collected. LMWH prophylaxis was used for DVT in all the patients. The incidence and risk factors of DVT after surgery were identified by logistic regression analysis and receiver operating characteristic (ROC) curve analysis. The overall incidence of postoperative DVT was 18.91% (101/534). Three patients (0.56%) had proximal DVT and ninety-eight (18.35%) patients had distal DVT. The incidence of postoperative DVT in patients with thoracic fractures was 26.80% and 15.50% with lumbar fractures. The multivariate analysis showed that six risk factors increased the incidence of postoperative DVT, including advanced age, decreased lower extremity motor, blood transfusion, duration of bed rests, fibrinogen (FIB), and D-dimer. The ROC analysis indicated that the diagnostic value of D-dimer was highest whose area under the ROC curves (AUC) value was 0.754. Despite LMWH prophylaxis, the risk of postoperative DVT is still very high, especially in thoracic fracture. Advanced age, decreased lower extremity motor, blood transfusion, duration of bed rests, FIB, and D-dimer are risk factors for DVT. Moreover, the diagnostic value of D-dimer is the highest among these factors.
引用
收藏
页码:397 / 404
页数:8
相关论文
共 50 条
  • [21] Postoperative versus preoperative initiation of deep-vein thrombosis prophylaxis with a low-molecular-weight heparin (Nadroparin) in elective hip replacement
    Palareti, G
    Borghi, B
    Coccheri, S
    Leali, N
    Golfieri, R
    Montebugnoli, M
    Inghilleri, G
    Ronzio, A
    Barbui, T
    Pogliani, EM
    DiNino, G
    Spotorno, L
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1996, 2 (01) : 18 - 24
  • [22] The effects of location and low-molecular-weight heparin administration on deep vein thrombosis outcomes in trauma patients
    Lee, Tim H.
    Alonzo, Brock J.
    Differding, Jerome
    Underwood, Samantha J.
    Hamilton, Greg
    Kremenevskiy, Igor
    McNamara, Steve
    Schreiber, Martin A.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2013, 74 (02) : 476 - 481
  • [23] Point of care ultrasound (POCUS) in diagnosis of proximal deep vein thrombosis among COVID-19 hospitalized patients with a high rate of low molecular weight heparin prophylaxis
    Garcia-Ceberino, Pedro M.
    Faro-Miguez, Naya
    Beltran-Avila, Francisco Javier
    Fernandez-Reyes, Daniel
    Gallardo-Munoz, Inmaculada
    Guirao-Arrabal, Emilio
    MEDICINA CLINICA, 2021, 157 (04): : 172 - 175
  • [24] Prevention of Deep Vein Thrombosis by Panax Notoginseng Saponins Combined with Low-Molecular-Weight Heparin in Surgical Patients
    Chun-mei Wang
    Xiang-feng Guo
    Li-min Liu
    Ying Huang
    Liang Meng
    Li-po Song
    Ying-feng Wu
    Ya-chan Ning
    Kathleen H. Reilly
    Hai-bo Wang
    Chinese Journal of Integrative Medicine, 2022, 28 : 771 - 778
  • [25] Can all patients with deep vein thrombosis receive low-molecular-weight heparin in an outpatient setting?
    Lindmarker, P
    HAEMOSTASIS, 1999, 29 : 84 - 88
  • [26] ASSOCIATION BETWEEN PLASMA-LEVELS OF TISSUE PLASMINOGEN-ACTIVATOR AND POSTOPERATIVE DEEP-VEIN THROMBOSIS - INFLUENCE OF PROPHYLAXIS WITH A LOW-MOLECULAR-WEIGHT HEPARIN
    SORENSEN, JV
    BORRIS, LC
    LASSEN, MR
    CHRISTIANSEN, HM
    SCHOTT, P
    OLSEN, AD
    NEERSTRAND, HS
    THROMBOSIS RESEARCH, 1990, 59 (01) : 131 - 138
  • [27] ROLE OF TISSUE FACTOR PATHWAY INHIBITOR IN POST SURGICAL DEEP VENOUS THROMBOSIS (DVT) PROPHYLAXIS IN PATIENTS TREATED WITH LOW-MOLECULAR-WEIGHT HEPARIN
    KIJOWSKI, R
    HOPPENSTEADT, D
    WALENGA, J
    BORRIS, L
    LASSEN, MR
    FAREED, J
    THROMBOSIS RESEARCH, 1994, 74 (01) : 53 - 64
  • [28] Low molecular weight heparin reduces the incidence of deep venous thrombosis in high-risk medical patients
    Steele A.
    Critical Care, 2 (1):
  • [29] Low Molecular Weight Heparin Is Superior for Venous Thromboembolism Prophylaxis in High-Risk Geriatric Patients
    Deusenberry, Christina M.
    Bardsley, Casey
    Sharon, Mindy
    Hobbs, Gerald R.
    Wilson, Alison M.
    Bardes, James M.
    AMERICAN SURGEON, 2023, 89 (12) : 5837 - 5841
  • [30] Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin
    Lindhoff-Last, E
    Nakov, R
    Misselwitz, F
    Breddin, HK
    Bauersachs, R
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (04) : 1137 - 1142